James S Heyward

6PUBLICATIONS
13CO-AUTHORS
Disease surveillanceEpidemiological modellingBehavioural epidemiologyDigital healthPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 17, 2025
Validation of Immune-Related Adverse Event (irAE) Case Definitions in a Real-World Lung Cancer Population.

James S Heyward, Jodi B Segal, Hemalkumar B Mehta

|Mar 20, 2023
Assessing Heterogeneity of Treatment Effect in Real-World Data.

Jodi B Segal, Ravi Varadhan, Rolf H H Groenwold

|Apr 21, 2021
Ambulatory noninsulin treatment of type 2 diabetes mellitus in the United States, 2015 to 2019.

James Heyward, Jacob Christopher, Sudipa Sarkar

|Nov 16, 2020
Telemedicine and Office-Based Care for Behavioral and Psychiatric Conditions During the COVID-19 Pandemic in the United States.

Omar Mansour, Matthew Tajanlangit, James Heyward

|Sep 28, 2020
Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018.

James Heyward, Thomas J Moore, Jennifer Chen

Pageof 1